DRUG · Unmapped registry intervention
NM-101
Find medicine records ·
Find other trials using this name
Clinical trial
Single and Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of NM-101
NCT05790382
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedSingle and Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of NM-101
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Parkinson Diseaseverified · MONDO: Parkinson disease
Interventions
Sponsors & collaborators
Neuramedy Co. Ltd.lead sponsor
Quotient Sciencescollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05790382 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.